The Pharma Data

MARCH 22, 2021

Ann Falsey, Professor of Medicine, University of Rochester School of Medicine, US, and co-lead Principal Investigator for the trial, said: “These findings reconfirm previous results observed in AZD1222 trials across all adult populations but it’s exciting to see similar efficacy results in people over 65 for the first time. JPEO-CBRND.

Trials 52

Trials Vaccination Vaccine Radiology 52

The Pharma Data

NOVEMBER 24, 2020

a postdoctoral researcher from the University of California San Diego School of Medicine. “This increased sensitivity in a subgroup is also seen in other studies on tobacco smokers, and there may be a genetic basis that predisposes some individuals to be more susceptible to their environment,” Dr. Kizhakke Puliyakote said.

Radiology 52

Radiology Research Genetics Scientist 52

Delveinsight

DECEMBER 10, 2020

Scientists at the University of Utah School of Medicine have found a way to control that autoimmune response by aiming a protein that is vital for T-cell activation. The body’s immune system falsely attacks insulin-making beta cells in the pancreas in Type 1 diabetes. The protein is known as OCA-B.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

The Pharma Data

AUGUST 22, 2021

Levin, MD, Professor of Pediatrics and Medicine, University of Colorado School of Medicine, US, and principal investigator on the trial, said: “The PROVENT data show that one dose of AZD7442, delivered in a convenient intramuscular form, can quickly and effectively prevent symptomatic COVID-19. W911QY-21-9-0001. Liu C, et al.

Trials 52

Trials Antibody Vaccination Vaccine 52

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Targeting the CNS directly has been successful in modern medicine. Next Steps for Targeted CNS Delivery. The patients are waiting!

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

NOVEMBER 7, 2022

Dr. Bahassi explained that technological advances in genetic sequencing of cfDNA have enabled liquid biopsies and led to marked increase in the detection of therapeutically-targetable mutations. FoundationOne ® Liquid CDx (Foundation Medicine; end-to-end commercial provider). Bahassi during the webinar and is shown in Table 1.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Intouch Solutions

SEPTEMBER 27, 2024

Biomarkers: The data and insights around precision oncology and personalized medicine continue to grow at an incredible pace. Our industry is making great strides toward individualized therapies that tailor treatment plans to the unique genetic makeup of each patient’s tumor. One of the trends I’ve seen is really meaningful.

DNA 59

DNA Trials Antibody Marketing 59

XTalks

SEPTEMBER 11, 2024

“Failure to study medications and other interventions in a broad sampling has led to women experiencing adverse effects from medications at nearly twice the rate of men ,” says Dr. Jaclyn Jansen, MD, MS, Medical Director of the Medical Department, General Medicine, Medpace. Precision medicine benefits breast cancer treatment.

Clinical Trials 103

Clinical Trials Clinical Trials Trials Hormones 103

The Pharma Data

APRIL 7, 2023

3) Some lung cancers are linked to acquired genetic abnormalities. 5) Precision medicine is increasingly being developed for NSCLC patients with genetic changes, such as BRAF mutations, that can be detected using biomarker tests.(6,7) 2) NSCLC accounts for approximately 80-85% of all lung cancers.(3)

FDA Approval 40

FDA Approval Drugs Medicine Genetics 40

Delveinsight

DECEMBER 29, 2020

X-linked myotubular myopathy (XLMTM) is a rare genetic neuromuscular disorder and leads to muscle weakness, respiratory failure, and early death. The ASPIRO trial is a two-part, open-label ascending dose study, and is examining the safety and preliminary efficacy of AT132 in children with XLMTM younger than five years old.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

AUGUST 15, 2021

Until today, there were no systemic therapies approved to help treat patients diagnosed with certain types of VHL-associated tumors,” said Dr. Eric Jonasch, principal investigator of Study 004 and professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center.

Hormones 52

Hormones Clinical Trials Clinical Trials Trials 52

XTalks

SEPTEMBER 14, 2020

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. Several laboratories have already shown that they can detect genetic material from the virus in wastewater. million confirmed cases with over 72,000 deaths.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92